findmyKOL
Clinical trialNCT01517984TerminatedPhase 2Interventional

Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment52Kidney Transplant Recipients
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study will compare how well transplanted kidneys work and the response of people's immune systems as tacrolimus, a calcineurin inhibitor (CNI), is withdrawn. In addition, this research study will evaluate whether reducing immunosuppression can decrease some of these side effects while still preventing rejection of the kidney.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Health Sciences Centre

    Winnipeg, Manitoba, Canada

  • Toronto General Hospital

    Toronto, Ontario, Canada

United States
  • University of California Los Angeles

    Los Angeles, California, United States

  • Yale University School of Medicine

    New Haven, Connecticut, United States

  • Brigham & Women'S Hospital

    Boston, Massachusetts, United States

  • University of Michigan Hospital

    Ann Arbor, Michigan, United States

  • Washington University

    St Louis, Missouri, United States

  • Mount Sinai School of Medicine

    New York, New York, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • University Hospitals of Cleveland

    Cleveland, Ohio, United States

  • the Methodist Hospital

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Standard Immunosuppressive TherapyTacrolimus Withdrawal
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2010
Primary completion
31 May 2015
Completion
31 May 2015
Last update posted
11 Sept 2017
Registered enrollment
52
Registry id
NCT01517984
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.